Michelson Medical Research Foundation’s Alexandria Real Estate Equities ARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37,230
Closed -$3.63M 26
2024
Q4
$3.63M Hold
37,230
3.04% 13
2024
Q3
$4.42M Hold
37,230
3.12% 14
2024
Q2
$5M Hold
37,230
4.3% 9
2024
Q1
$4.8M Hold
37,230
2.91% 13
2023
Q4
$4.72M Hold
37,230
3.11% 13
2023
Q3
$3.73M Hold
37,230
2.52% 13
2023
Q2
$4.23M Hold
37,230
3.01% 13
2023
Q1
$4.68M Hold
37,230
3.67% 12
2022
Q4
$5.42M Buy
+37,230
New +$5.38M 3.51% 10

Other funds holding ARE

Michelson Medical Research Foundation's ARE Position: Q1 2025 in Review

Michelson Medical Research Foundation sold out of Alexandria Real Estate Equities (ARE) in Q1 2025, closing a stake of 37,230 shares — an estimated $3.63M sold.

Michelson Medical Research Foundation first reported a position in ARE in Q4 2022 and held it in 9 quarters. The position peaked at $5.42M in Q4 2022. 668 funds tracked by Wall St. Rank hold ARE as of Q1 2025.

  • Michelson Medical Research Foundation reported no remaining Alexandria Real Estate Equities position as of Q1 2025 after selling out during the quarter.
  • Michelson Medical Research Foundation sold 37,230 Alexandria Real Estate Equities shares in Q1 2025, an estimated $3.63M.
  • Michelson Medical Research Foundation first reported a position in Alexandria Real Estate Equities in Q4 2022 and held it in 9 quarters.
  • Michelson Medical Research Foundation's Alexandria Real Estate Equities position peaked at $5.42M in Q4 2022.
  • 668 funds tracked by Wall St. Rank held Alexandria Real Estate Equities as of Q1 2025.

Based on Michelson Medical Research Foundation's 13F filing for Q1 2025, filed 15 May 2025.